Brief: Alzinova Starts Extension Part Of Phase 1b Study With ALZ-101
29/05/2023 12:09
May 29 (Reuters) - Alzinova AB ALZ.ST :
* FIRST PATIENT DOSED IN THE EXTENSION PART OF THE PHASE 1B
STUDY
WITH ALZ-101
* EXTENSION PART OF ONGOING PHASE 1B STUDY HAS BEEN
INITIATED BY
DOSING FIRST PATIENT WITH VACCINE CANDIDATE ALZ-101
Source text for Eikon: ID:nMFN6lXyQF
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))